These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12351454)

  • 1. In vivo evidence for increased oxidation of circulating LDL in impaired glucose tolerance.
    Kopprasch S; Pietzsch J; Kuhlisch E; Fuecker K; Temelkova-Kurktschiev T; Hanefeld M; Kühne H; Julius U; Graessler J
    Diabetes; 2002 Oct; 51(10):3102-6. PubMed ID: 12351454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of association between serum paraoxonase 1 activities and increased oxidized low-density lipoprotein levels in impaired glucose tolerance and newly diagnosed diabetes mellitus.
    Kopprasch S; Pietzsch J; Kuhlisch E; Graessler J
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1711-6. PubMed ID: 12679462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum oxidized low density lipoprotein, paraoxonase 1 and lipid peroxidation levels during oral glucose tolerance test.
    Serin O; Konukoglu D; Firtina S; Mavis O
    Horm Metab Res; 2007 Mar; 39(3):207-11. PubMed ID: 17373636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum lipid and hsCRP levels in prediabetes--impaired fasting glucose (IFG) and impaired glucose tolerance (IGT).
    Chakarova N; Tankova T; Atanassova I; Dakovska L
    Diabetes Res Clin Pract; 2009 Oct; 86(1):56-60. PubMed ID: 19674805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid profile and its relation to fasting insulin level in non-insulin dependent diabetes mellitus (NIDDM).
    Uddin F; Miah AK
    Bangladesh Med Res Counc Bull; 1995 Aug; 21(2):64-72. PubMed ID: 8815864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic heterogeneity in impaired glucose tolerance.
    Walker M; Berrish TS; Stewart MW; Humphriss DB; Barriocanal L; Alberti KG
    Metabolism; 1997 Aug; 46(8):914-7. PubMed ID: 9258274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with a pro-atherogenic lipid profile.
    Andreozzi F; Mannino GC; Perticone M; Perticone F; Sesti G
    Atherosclerosis; 2017 Jan; 256():15-20. PubMed ID: 27940375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes.
    Tsuzura S; Ikeda Y; Suehiro T; Ota K; Osaki F; Arii K; Kumon Y; Hashimoto K
    Metabolism; 2004 Mar; 53(3):297-302. PubMed ID: 15015140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation.
    Jenkins AJ; Klein RL; Chassereau CN; Hermayer KL; Lopes-Virella MF
    Diabetes; 1996 Jun; 45(6):762-7. PubMed ID: 8635650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM.
    Haffner SM; Agil A; Mykkanen L; Stern MP; Jialal I
    Diabetes Care; 1995 May; 18(5):646-53. PubMed ID: 8586002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline diene conjugation in LDL lipids from newly diagnosed type 2 diabetic patients.
    Gavella M; Lipovac V; Car A; Vucic M
    Diabetes Metab; 2002 Nov; 28(5):391-6. PubMed ID: 12461476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irisin levels in the progression of diabetes in sedentary women.
    Duran ID; Gülçelik NE; Ünal M; Topçuoğlu C; Sezer S; Tuna MM; Berker D; Güler S
    Clin Biochem; 2015 Dec; 48(18):1268-72. PubMed ID: 26234637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of triglycerides for other metabolic parameters in the familial metabolic syndrome].
    Metzler W; Fücker K; Schwanebeck U; Hanefeld M; Julius U; Kindel B; Fischer S
    Dtsch Med Wochenschr; 2003 Sep; 128(38):1941-6. PubMed ID: 14502445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. The Insulin Resistance Atherosclerosis Study.
    Festa A; D'Agostino R; Mykkänen L; Tracy RP; Hales CN; Howard BV; Haffner SM
    Diabetes Care; 1999 Oct; 22(10):1688-93. PubMed ID: 10526736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertriglyceridemia in different degrees of glucose intolerance in a Finnish population-based study.
    Salomaa VV; Tuomilehto J; Jauhiainen M; Korhonen HJ; Stengård J; Uusitupa M; Pitkanen M; Penttila I
    Diabetes Care; 1992 May; 15(5):657-65. PubMed ID: 1516486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients.
    Watanabe N; Taniguchi T; Taketoh H; Kitagawa Y; Namura H; Yoneda N; Kurimoto Y; Yamada S; Ishikawa Y
    Diabetes Care; 1999 Jan; 22(1):152-6. PubMed ID: 10333918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low serum adiponectin is associated with high circulating oxidized low-density lipoprotein in patients with type 2 diabetes mellitus and coronary artery disease.
    Lautamäki R; Rönnemaa T; Huupponen R; Lehtimäki T; Iozzo P; Airaksinen KE; Knuuti J; Nuutila P
    Metabolism; 2007 Jul; 56(7):881-6. PubMed ID: 17570246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-sectional and prospective associations between proinsulin and cardiovascular disease risk factors in a population experiencing rapid cultural transition.
    Hanley AJ; McKeown-Eyssen G; Harris SB; Hegele RA; Wolever TM; Kwan J; Connelly PW; Zinman B
    Diabetes Care; 2001 Jul; 24(7):1240-7. PubMed ID: 11423509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
    Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
    J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for diabetes and cardiovascular disease in young Australian aborigines. A 5-year follow-up study.
    Braun B; Zimmermann MB; Kretchmer N; Spargo RM; Smith RM; Gracey M
    Diabetes Care; 1996 May; 19(5):472-9. PubMed ID: 8732712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.